Literature DB >> 12376367

Muscarinic M2 receptors in acetylcholine-isoproterenol functional antagonism in human isolated bronchus.

Benjamin Sarria1, Emmanuel Naline, Yong Zhang, Julio Cortijo, Mathieu Molimard, Joelle Moreau, Patrice Therond, Charles Advenier, Esteban J Morcillo.   

Abstract

The muscarinic functional antagonism of isoproterenol relaxation and the contribution of muscarinic M2 receptors were examined in human isolated bronchus. In intact tissues, acetylcholine (ACh) precontraction decreased isoproterenol potency and maximal relaxation (-log EC50 shift = -1.49 +/- 0.16 and E(max) inhibition for 100 microM ACh = 30%) more than the same levels of histamine contraction. The M2 receptor-selective antagonist methoctramine (1 microM) reduced this antagonism in ACh- but not histamine-contracted tissues. Similar results were obtained for forskolin-induced relaxation. After selective inactivation of M3 receptors with 4-diphenylacetoxy-N-(2-chloroethyl)piperadine hydrochloric acid (30 nM), demonstrated by abolition of contractile and inositol phosphate responses to ACh, muscarinic recontractile responses were obtained in U-46619-precontracted tissues fully relaxed with isoproterenol. Methoctramine antagonized recontraction, with pK(B) (6.9) higher than in intact tissues (5.4), suggesting participation of M2 receptors. In M3-inactivated tissues, methoctramine augmented the isoproterenol relaxant potency in U-46619-contracted bronchus and reversed the ACh-induced inhibition of isoproterenol cAMP accumulation. These results indicate that M2 receptors cause indirect contraction of human bronchus by reversing sympathetically mediated relaxation and contribute to cholinergic functional antagonism.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12376367     DOI: 10.1152/ajplung.00084.2002

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  12 in total

1.  Bronchodilator activity of bitter tastants in human tissue.

Authors:  Maria G Belvisi; Nicole Dale; Mark A Birrell; Brendan J Canning
Journal:  Nat Med       Date:  2011-07-07       Impact factor: 53.440

2.  Effects of ouabain on human bronchial muscle in vitro.

Authors:  Julio Cortijo; Benjamín Sarria; Manuel Mata; Emmanuel Naline; Charles Advenier; Esteban J Morcillo
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-10-15       Impact factor: 3.000

Review 3.  Using guinea pigs in studies relevant to asthma and COPD.

Authors:  Brendan J Canning; Yangling Chou
Journal:  Pulm Pharmacol Ther       Date:  2008-02-02       Impact factor: 3.410

4.  Muscarinic receptor subtypes and signalling involved in the attenuation of isoprenaline-induced rat urinary bladder relaxation.

Authors:  Lambertus P W Witte; Noach de Haas; Mathai Mammen; Eric L Stangeland; Tod Steinfeld; Jayashree Aiyar; Martin C Michel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-09-24       Impact factor: 3.000

Review 5.  The pharmacological rationale for combining muscarinic receptor antagonists and β-adrenoceptor agonists in the treatment of airway and bladder disease.

Authors:  Philippa R Dale; Hana Cernecka; Martina Schmidt; Mark R Dowling; Steven J Charlton; Michael P Pieper; Martin C Michel
Journal:  Curr Opin Pharmacol       Date:  2014-03-27       Impact factor: 5.547

6.  Involvement of Allosteric Effect and KCa Channels in Crosstalk between β₂-Adrenergic and Muscarinic M₂ Receptors in Airway Smooth Muscle.

Authors:  Hiroaki Kume; Osamu Nishiyama; Takaaki Isoya; Yuji Higashimoto; Yuji Tohda; Yukihiro Noda
Journal:  Int J Mol Sci       Date:  2018-07-09       Impact factor: 5.923

7.  Cooperativity between β-agonists and c-Abl inhibitors in regulating airway smooth muscle relaxation.

Authors:  Ajay P Nayak; John M Lim; Eylon Arbel; Ruping Wang; Dominic R Villalba; Tahn L Nguyen; Niccole Schaible; Ramaswamy Krishnan; Dale D Tang; Raymond B Penn
Journal:  FASEB J       Date:  2021-07       Impact factor: 5.834

8.  Overcoming beta-agonist tolerance: high dose salbutamol and ipratropium bromide. Two randomised controlled trials.

Authors:  Sarah Haney; Robert J Hancox
Journal:  Respir Res       Date:  2007-03-06

Review 9.  Acetylcholinesterase Inhibitors and Drugs Acting on Muscarinic Receptors- Potential Crosstalk of Cholinergic Mechanisms During Pharmacological Treatment.

Authors:  Ondrej Soukup; Michael Winder; Uday Kumar Killi; Vladimir Wsol; Daniel Jun; Kamil Kuca; Gunnar Tobin
Journal:  Curr Neuropharmacol       Date:  2017       Impact factor: 7.363

10.  Selective inhibition of histamine-evoked Ca2+ signals by compartmentalized cAMP in human bronchial airway smooth muscle cells.

Authors:  Philippa Dale; Victoria Head; Mark R Dowling; Colin W Taylor
Journal:  Cell Calcium       Date:  2017-12-15       Impact factor: 6.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.